VC  Kegonsa Capital Partners

http://www.kegonsapartners.com





     Office Locations:

5520 Nobel Drive, Suite 150
Fitchburg, WI 53711
Phone: 608-205-0100

 

Stages:

  • Early
  • Growth
  • Seed


 

Industries:

  • Information Technology

  •  

    Description:

    Kegonsa Capital Partners, LLC is a leading Wisconsin venture capital management firm. KCP is the general partner of the Kegonsa Seed Fund I, LP, a seed venture capital fund, and the Kegonsa Coinvest Fund, LLC, an early stage growth venture capital fund. The Kegonsa Seed Fund I, LP had its final closing January 15, 2005. The Fund's committed capital is $10.725 million. Eleven of the 13 initial investments were seed venture capital investments (i.e., companies without revenues); 25 percent of the portfolio companies were created by Kegonsa Capital Partners management. In October 2007, the Fund experienced its first liquidity event when Jellyfish.com, a Fund portfolio company, was purchased for cash by Microsoft. This exit provided a return to Limited Partners of 15 times the Fund's initial investment. In May 2012, the Fund experienced its second liquidity event when Intelligent BioSystems, Inc, a Fund portfolio company, was purchased by QIAGEN. The exit provided a return of over three times the Fund's initial investment. The Fund's investment period ended January 15, 2010. To date, two of the 13 portfolio companies have failed and have been dissolved. Two portfolio companies have experienced an exit; one company completed a stock redemption repurchasing the Fund's stock; and eight companies are ongoing. The Seed Fund has a Wisconsin focus, as all eleven seed investments were made in companies headquartered in Wisconsin. In addition, one growth stage investment was made in a Boston company that was originally from Wisconsin. The Kegonsa Coinvest Fund is a Wisconsin-based growth stage investment fund. Since 2007 the Fund has made 13 investments totaling $7.6 million. 12 of the investments were in growth-stage companies (i.e., companies with revenue from product sales but who are not yet cash flow break even). The remaining investment was a late stage investment in which the Fund participated in an offering led by Goldman Sachs. Of the Fund's 13 investments, ten were made as part of a syndicate. Five of the ten syndicate offerings were led by the Fund. To date, one Fund portfolio company has had an exit; one portfolio company has been dissolved; and the remaining companies are ongoing. All of the Coinvest Fund portfolio companies are headquartered in Wisconsin.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Kenneth U. Johnson

     

    Portfolio companies include:


      Alice.com
        web link


      Brazen Careerist
        web link


      Idle Free Systems
        web link


      Intelligent Bio Systems
        web link


      Jellyfish
        web link


      NanoMedex Pharmaceuticals
        web link


      Networked Insights
        web link


      Semba Biosciences
        web link


      Stealth Therapeutics
        web link


      U.S. TrailMaps
        web link


     

    Recent News: